Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;58(5):241-247.
doi: 10.1358/dot.2022.58.5.3381591.

Fluticasone propionate as a potential treatment for COVID-19

Affiliations

Fluticasone propionate as a potential treatment for COVID-19

Matthew W McCarthy. Drugs Today (Barc). 2022 May.

Abstract

Outpatient treatment options for mild to moderate COVID-19 are severely limited. While many therapeutic options have been proposed, very few have demonstrated the appropriate safety and efficacy to warrant approval by national or international regulatory bodies. Monoclonal antibodies have been shown to decrease hospitalization in high-risk patients, but use remains limited due to challenges associated with both production and administration, and other treatment options are urgently needed. The anti-inflammatory drug fluticasone propionate has recently emerged as a potential outpatient treatment option, especially for those with newly diagnosed disease. This manuscript reviews what is known about fluticasone and looks ahead to examine how the drug may be used in the future to address the COVID-19 pandemic.

Keywords: COVID-19; Drug repurposing; Fluticasone propionate; Glucocorticoid receptor agonists; Inhaled corticosteroids; SARS-CoV-2 infection.

PubMed Disclaimer

Similar articles

Cited by